United Health Products Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
| (1) | Financial Statements |
| The financial statements of United Health Products, Inc., supplemental information and report of independent registered public accounting firm are included in this Form 10-K. |
| (2) | Financial Statement Schedules |
Schedules have been omitted because of the absence of conditions under which they are required or because the required information is included in the financial statements or notes thereto.
| (3) | Exhibits | |
| (a) | Exhibits |
The following exhibits are filed with this report, or incorporated by reference as noted:
| 3.1 | Articles of Incorporation of the Company dated February 28, 1997 (1) |
| 3.2 | Amendment to Articles of Incorporation (1) |
| 3.3 | By-laws of the Company (2) |
| 3.4 | August 2015 Amendment to Articles of Incorporation (3) |
| 10.1 | Services Agreement with Louis Schiliro (4) |
| 10.2 | Restricted Stock Unit Agreement – Louis Schiliro (5) |
| 10.3 | Services Agreement with Brian Thom (6) |
| 10.4 | Restricted Stock Unit Agreement - Brian Thom (6) |
| 10.5 | Services Agreement with Kristofer Heaton (7) |
| 10.6 | Restricted Stock Unit Agreement - Kristofer Heaton (7) |
| 10.7 | Amendment to Restricted Stock Unit Agreement – Brian Thom (8) |
| 10.8 | Restricted Stock Unit Agreement – Robert Denser (8) |
| 10.9 | Stock Purchase Agreement dated September 1, 2022 between the Company and White Lion Capital LLC (9) |
| 10.10 | Amendment to Stock Purchase Agreement dated January 25, 2023 (10) |
| 21 | Subsidiaries of the Registrant – none |
| 31.1 | Certification of Principal Executive Officer* |
| 31.2 | Certification of Principal Financial Officer* |
| 32.1 | Section 1350 Certificate by Principal Executive Officer* |
| 32.2 | Section 1350 Certificate by Principal Financial Officer* |
| 99.1 | 2019 Employee Benefit and Consulting Services Compensation Plan (11) |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
| * | Filed herewith. |
| (1) | Incorporated by reference to the Company’s Form 10-Q for the quarter ended September 30, 2014. |
| (2) | Incorporated by reference to the Company’s Form 10-Q for the quarter ended June 30, 2022. |
| (3) | Incorporated by reference to Form 8-K dated August 7, 2015 – date of earliest event filed on August 10, 2015. |
| (4) | Incorporated by reference to the Company’s Form 10-Q for the quarter ended June 30, 2018. |
| (6) | Incorporated by reference to the Form 8-K dated December 2, 2020 |
| (7) | Incorporated by reference to the Form 8-K dated January 11, 2021 |
| (8) | Incorporated by reference to the Form 8-K dated June 23, 2022 |
| (9) | Incorporated by reference to the Form 8-K dated September 1, 2022 |
| (11) | Incorporated by reference to Form S-8 dated November 1, 2019 |
SIGNATURES
Pursuant to the requirements Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| UNITED HEALTH PRODUCTS, INC. | ||
| Dated: April 1, 2024 | By: | /s/ Brian Thom |
|---|---|---|
| Brian Thom | ||
| Chief Executive OfficerPrincipal Executive Officer and Director | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
| Signatures | Title | Date | |||
|---|---|---|---|---|---|
| By: | /s/ Brian Thom | Chief Executive Officer, Principal | April 1, 2024 | ||
| Brian Thom | Executive Officer and Director | ||||
| By: | /s/ Kristofer Heaton | Principal Financial Officer | April 1, 2024 | ||
| Kristofer Heaton | |||||
| By: | /s/ Robert Denser | Director | April 1, 2024 | ||
| Robert Denser | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.